ask="24.75"
ask_size="200"
average_daily_volume="406805"
bid="19.20"
bid_size="1000"
book_value="8.16"
change="+0.42"
change_from_200_day_moving_average="0.98"
change_from_50_day_moving_average="1.37"
change_from_52_week_high="-3.64"
change_From_52_week_low="9.33"
change_in_percent="+2.05%"
close="20.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.14"
ebitda="-16.56M"
eps_estimate_current_year="-1.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="21949000"
high="21.05"
high_52_weeks="24.57"
last_trade_date="2/15/2017"
last_trade_price="20.93"
last_trade_size="17688"
last_trade_time="4:00pm"
low="20.27"
low_52_weeks="11.60"
market_capitalization="789.73M"
moving_average_200_day="19.95"
moving_average_50_day="19.56"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="34.67"
open="20.50"
pe_ratio="N/A"
peg_ratio="-0.80"
percent_change_from_200_day_moving_average="+4.92%"
percent_change_from_50_day_moving_average="+7.03%"
percent_change_from_52_week_high="-14.81%"
percent_change_from_52_week_low="+80.43%"
previous_close="20.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.51"
price_per_sales="6.11"
revenue="126.71M"
shares_outstanding="37732000"
short_ratio="13.94"
stock_exchange="NGM"
symbol="RTRX"
volume="337048"
weeks_range_52="11.60 - 24.57"
